Emily Paolillo: What is MCI and How Is It Diagnosed?
For people living with dementia and their caregivers, the term Mild Cognitive Impairment (MCI) may be familiar. Often the first diagnosis many patients receive,…
For people living with dementia and their caregivers, the term Mild Cognitive Impairment (MCI) may be familiar. Often the first diagnosis many patients receive,…
A brain stimulation technique called transcranial magnetic stimulation (TMS) is sparking the attention of neurologists around the globe. In the U.S., it’s already FDA…
Xanax and other benzodiazepines (“benzos”) are often prescribed to treat symptoms like agitation, anxiety, and depression in people living with dementia. Yet, these drugs…
Is dementia preventable? Research shows that yes, sometimes, it is. Scientists project that the number of people living with dementia, a neurodegenerative syndrome which…
One day, Don Kent’s personality started changing. A cool, even-keeled lawyer, he found himself suddenly losing control of his emotions. At the same time,…
Living with dementia can present unique challenges for older adults and their loved ones. Incorporating suitable games into their daily routines can have a…
Dementia is most widely associated with its cognitive symptoms, like memory loss. But it often brings a host of behavioral symptoms, too, like agitation…
If you could get a $400 blood test that tells you within 10 days whether you’re likely to develop Alzheimer’s disease years or decades…
Lewy body dementia is the second most common form of dementia. Where Alzheimer’s disease makes up 70 percent of dementia cases, Lewy body makes…
Lewy Body dementia is the second most common form of dementia, but one of the most frequently misdiagnosed. One thing that makes LBD just…
There are a number of different ways that COVID-19 can leave its mark on the brain. Some are life-threatening — from severe brain-swelling to…
About 1.7 million Americans have taken up use of a substance called kratom — an herbal extract from the leaves of a tropical tree…
It was 7:20 a.m. and Joel Braunstein, co-founder and CEO of C2N Diagnostics, was about to start his second meeting of the day. C2N…
There are dozens of new approaches to treating Alzheimer’s currently in clinical trials. But while some promising innovations in diagnostics and intervention are progressing…
Alzheimer’s disease affects one in every three people over the age of 85, and the scale of the epidemic is only worsening. While there…